Evaluation of the Fleetwood Model of Long-Term Care Pharmacy

Journal of the American Medical Directors Association

Volumn 12, Issue 5, 2011, Pages 355-363

  Lapane, Kate L ^a,b   Hughes, Carmel M ^c   Christian, Jennifer B ^b   Daiello, Lori A ^b   Cameron, Kathleen A ^d   Feinberg, Janice ^d  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b RHODE ISLAND HOSPITAL   (United States)

^c QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^d American Society of Consultant Pharmacists Foundation   (United States)

Author keywords

Medication use, inappropriate medication use, policy; Nursing homes; Pharmacist

Indexed keywords

ADULT; AGED; ARTICLE; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; DRUG EFFECT; DRUG INDICATION; DRUG UTILIZATION; FEMALE; FLEETWOOD MODEL; HEALTH CARE PLANNING; HEALTH CARE POLICY; HOSPITALIZATION; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MEDICATION ERROR; MODEL; NURSING HOME PATIENT; NURSING HOME PERSONNEL; PHARMACEUTICAL CARE; PHARMACIST; UNITED STATES;

EID: 79956275120     PISSN: 15258610     EISSN: 15389375     Source Type: Journal    
DOI: 10.1016/j.jamda.2010.03.003     Document Type: Article

References (33)

1. OBRA (Omnibus Budget Reconciliation Act) 1987. US Congress. Public Law 101-508.
2. Stoudemire A., Smith D.A. OBRA regulations and the use of psychotropic drugs in long-term care facilities: Impact and implications for geropsychiatric care. Gen Hosp Psychiatry 1996, 18:77-94.
3. Elon R., Pawlson L.G. The impact of OBRA on medical practices within nursing facilities. J Am Geriatr Soc 1992, 40:958-963.
4. Office of the Inspector General Prescription Drug Use in Nursing Homes. In Report 2: An Inside View by Consultant Pharmacists 1997, Department of Health and Human Services; Washington, DC., Report No. OEI-06-96-00081.
5. Rancourt C., Moisan J., Baillargeon L., et al. Potentially inappropriate prescriptions for older patients in long-term care. BMC Geriatr 2004, 4:9.
6. Cameron K., Feinberg J.L., Lapane K.L. Fleetwood Project Phase III moves forward. Consult Pharm 2002, 17:180-200.
7. Bootman J.L., Harrison D.L., Cox E. The health care cost of drug-related morbidity and mortality in nursing facilities. Arch Intern Med 1997, 157:2089-2096.
8. Daschner M., Brownstein S., Cameron K.A., et al. Fleetwood Phase II tests a new model of long term care pharmacy. Consult Pharm 2000, 15:989-1005.
9. Lapane K.L., Hughes C.M. Identifying nursing home residents at high-risk for preventable adverse drug events: Modifying a tool for use in the Fleetwood Phase III study. Consult Pharm 2004, 19:533-537.
10. Christian J.B., van Haaren A., Cameron K., et al. Alternatives of potentially inappropriate medications in the elderly: Treatment algorithms for use in the Fleetwood Phase III study. Consult Pharm 2004, 19:1011-1028.
11. Lapane K.L., Hiris J., Hughes C.M., et al. Development and implementation of pharmaceutical care planning software for nursing homes based on the Fleetwood Model. Am J Health Syst Pharm 2006, 63:2483-2487.
12. Lapane K.L., Hughes C.M. Adherence to the components of the Fleetwood Model: Self-reported process measures in the Fleetwood Phase III study. Consult Pharm 2006, 21:981-987.
13. Lapane K.L., Hughes C.M. Pharmaceutical care interventions undertaken by pharmacists in the Fleetwood Phase III study: The role of process control. Ann Pharmacother 2006, 40:1522-1526.
14. Clark T.R. Nursing Home Survey Procedures and Interpretive Guidelines 1999, American Society of Consultant Pharmacists, Alexandria, VA.
15. Beers M.H. Explicit criteria for determining potentially inappropriate medication use by the elderly. An update. Arch Intern Med 1997, 157:1531-1536.
16. Anonymous. Minimum Data Set Plus training manual 1991, Eliot Press, Natick, MA.
17. Morris J.N., Fries B.E., Mehr D.R., et al. MDS Cognitive performance scale. J Gerontol 1994, 49:M174-M182.
18. Hawes C., Morris J.N., Phillips C.D., et al. Reliability estimates for the Minimum Data Set for nursing home resident assessment and care screening (MDS). Gerontologist 1995, 35:172-178.
19. Fu A.Z., Liu G.G., Christensen D.B. Inappropriate medication use and health outcomes in the elderly. J Am Geriatr Soc 2004, 52:1934-1939.
20. Fick D.M., Cooper J.W., Wade W.E., et al. Updating the Beers criteria for potentially inappropriate medication use in older adults: Results of a US consensus panel of experts. Arch Intern Med 2003, 163:2716-2724.
21. Gurwitz J.H., Field T.S., Avorn J., et al. Incidence and preventability of adverse drug events in nursing homes. Am J Med 2000, 109:87-94.
22. Diggle P.J., Liang K.-Y., Zeger S.L. Analysis of Longitudinal Data 1994, Clarendon Press, Oxford.
23. SAS Institute Inc SAS/STAT software: Changes and enhancement through release 6.12 1997, SAS Institute Inc, Cary, NC.
24. Trygstad T.K., Christensen D., Garmise J., et al. Pharmacist response to alerts generated from Medicaid pharmacy claims in a long-term care setting: Results from the North Carolina polypharmacy initiative. J Manag Care Pharm 2005, 11:575-583.
25. Christensen D., Trygstad T., Sullivan R., et al. A pharmacy management intervention for optimizing drug therapy for nursing home patients. Am J Geriatr Pharmacother 2004, 2:248-256.
26. Roberts M.S., Stokes J.A., King M.A., et al. Outcomes of a randomized controlled trial of a clinical pharmacy intervention in 52 nursing homes. Br J Clin Pharmacol 2001, 51:257-265.
27. Zermansky A.G., Alldred D.P., Petty D.R., et al. Clinical medication review by a pharmacist of elderly people living in care homes-randomised controlled trial. Age Ageing 2006, 35:586-591.
28. Patterson S.M., Hughes C.M., Crealey G., et al. An evaluation of an adapted United States model of pharmaceutical care to improve psychoactive prescribing for nursing home residents in Northern Ireland (Fleetwood NI Study). J Am Geriatr Soc. 2010, 58:44-53.
29. Furniss L., Burns A., Craig S.K., et al. Effects of a pharmacist's medication review in nursing homes. Randomised controlled trial. Br J Psychiatry 2000, 176:563-567.
30. Loeb M., Brazil K., Lohfeld L., et al. Effect of a multifaceted intervention on number of antimicrobial prescriptions for suspected urinary tract infections in residents of nursing homes: Cluster randomised controlled trial. BMJ 2005, 331:669.
31. Lapane K.L., Hughes C.M. Job satisfaction and stress among pharmacists in the long term care sector. Consult Pharm 2006, 21:287-292.
32. Lapane K.L., Hughes C.M. Job satisfaction and stress among workers providing long-term care pharmacy services. Consult Pharm 2004, 19:1029-1037.
33. Holland R., Desborough J., Goodyer L., et al. Does pharmacist-led medication review help to reduce hospital admissions and death in older people? A systematic review and meta- analysis. Br J Clin Pharmacol 2008, 65:303-316.